All-in-one wearable drug efficacy assessment systems for bulbar muscle function using amyotrophic lateral sclerosis animal models
Open Access
- 9 August 2024
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-11
Abstract
Preclinical studies are crucial for developing amyotrophic lateral sclerosis drugs. Current FDA-approved drugs have been created by monitoring limb muscle function and histological analysis of amyotrophic lateral sclerosis model animals. Drug candidates for this disease have yet to be tested for bulbar-onset type due to the limitations of traditional preclinical tools: excessive animal use and discrete detection of disease progress. Here, our study introduces an all-in-one, wireless, integrated wearable system for facilitating continuous drug efficacy assessment of dysphagia-related muscles in animals during natural eating behaviors. By incorporating a kirigami-based strain-isolation mechanism, this device mounted on the skin of animals mitigates electromyography signal contamination caused by unpredictable animal movements. Our findings indicate this system, measuring the progression of motor neuron denervation, offers high precision in monitoring drug effects on dysphagia-responsible bulbar muscles. This study paves the way for more humane and efficient approaches to developing treatment solutions for degenerative neuromuscular diseases.Keywords
Funding Information
- U.S. Department of Health & Human Services | National Institutes of Health (R21EB031535)
This publication has 41 references indexed in Scilit:
- Kirigami‐Inspired Biodesign for Applications in HealthcareAdvanced Materials, 2022
- Graded Kirigami Composites for Programmed Strain DistributionsAdvanced Materials Technologies, 2021
- Real‐Time Functional Assay of Volumetric Muscle Loss Injured Mouse Masseter Muscles via Nanomembrane ElectronicsAdvanced Science, 2021
- Strain‐Isolating Materials and Interfacial Physics for Soft Wearable Bioelectronics and Wireless, Motion Artifact‐Controlled Health MonitoringAdvanced Functional Materials, 2021
- Optimizing the Translational Value of Mouse Models of ALS for Dysphagia Therapeutic DiscoveryDysphagia, 2019
- Edaravone: A new drug approved for ALSCell, 2017
- Ncorr: Open-Source 2D Digital Image Correlation Matlab SoftwareExperimental Mechanics, 2015
- Feasibility study for functional test battery of SOD transgenic rat (H46R) and evaluation of edaravone, a free radical scavengerBrain Research, 2011
- An Animal Model of Oral Dysphagia in Amyotrophic Lateral SclerosisDysphagia, 2008
- Treatment with edaravone, initiated at symptom onset, slows motor decline and decreases SOD1 deposition in ALS miceExperimental Neurology, 2008